Conger Daniel E 4

4 · Semler Scientific, Inc. · Filed Jun 4, 2018

Form 4

Period: 2018-06-01

Vice President of Finance

Transactions

Sale
Common Stock
2018-06-01$12.00/sh−29,500$354,000→ 0 total
Exercise/Conversion
Common Stock
2018-06-01$0.52/sh+6,500$3,380→ 13,000 total
Exercise/Conversion
Common Stock
2018-06-01$0.52/sh+10,000$5,200→ 29,500 total
Exercise/Conversion
Common Stock
2018-06-01$0.52/sh+6,500$3,380→ 19,500 total
Exercise/Conversion
Common Stock
2018-06-01$0.52/sh+6,500$3,380→ 6,500 total
Exercise/Conversion
Stock Option (Right to Buy)
2018-06-01−6,500→ 0 total
Exercise: $0.52Exp: 2021-06-10→ Common Stock (6,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-06-01−6,500→ 0 total
Exercise: $0.52Exp: 2022-01-05→ Common Stock (6,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-06-01−6,500→ 0 total
Exercise: $0.52Exp: 2020-11-01→ Common Stock (6,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2018-06-01−10,000→ 0 total
Exercise: $0.52Exp: 2022-11-21→ Common Stock (10,000 underlying)

Footnotes (2)

[F1]The price reported is a weighted average price. The shares were sold at prices ranging from $12.00 to $12.04. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
[F2]These options were granted pursuant to the Issuer's 2007 Key Person Stock Option Plan and are fully vested.

Documents

1 file